+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Hepatocellular carcinoma in the elderly: clinical characteristics, treatment, survival analysis in Korean patients older than 70 years



Hepatocellular carcinoma in the elderly: clinical characteristics, treatment, survival analysis in Korean patients older than 70 years



Journal of Korean Medical Science 27(10): 1147-1154



The prevalence of hepatocellular carcinoma (HCC) has increased in recent years. However, HCC remains poorly characterized in elderly patients, and comprehensive data are limited. This study aimed to investigate the clinical characteristics, prognostic features and survival outcome of elderly HCC patients. We retrospectively analyzed 992 HCC patients treated at Dongsan Hospital from January 2003 to December 2007. The patients were divided into two age groups: < 70 yr (n = 813) and ≥ 70 yr (n = 179). Elderly HCC patients, compared to younger patients, had significantly higher incidence of females (31.3% vs 18.9%, P = 0.001), hepatitis C-related disease (HCV antibody positivity 26.3% vs 9.2%, P = 0.001) and comorbid condition (53.6% vs 32.1%), but lower rates of hepatitis B-related disease (HBs antigen positivity 31.3% vs 69.4%, P = 0.001). There were no significant differences in underlying liver function, stage and survival outcomes. Factors significantly influencing the prognosis of HCC were Child-Pugh grade, number of HCC, level of alpha-fetoprotein, presence of metastasis. The survival outcome of older patients with HCC was not different from that of younger patients. There were no differences between groups in independent factors influencing the prognosis of HCC. Therefore, determining the optimal management strategy for elderly HCC patients is important to improve survival and long-term outcomes.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053519318

Download citation: RISBibTeXText

PMID: 23091310

DOI: 10.3346/jkms.2012.27.10.1147


Related references

Hepatocellular carcinoma in the elderly: clinical characteristics, survival analysis, and prognostic indicators in a cohort of Spanish patients older than 75 years. Revista Espanola de Enfermedades Digestivas 100(10): 625-631, 2008

Clinical characteristics, treatment patterns and survival outcome of hepatocellular carcinoma patients aged 70 years or older: a single-center retrospective study from China. Aging Clinical and Experimental Research 26(2): 123-130, 2014

Hepatocellular carcinoma in extremely elderly patients: an analysis of clinical characteristics, prognosis and patient survival. World Journal of Gastroenterology 12(1): 48-53, 2006

Clinical features of hepatocellular carcinoma in the elderly: a study of 91 patients older than 70 years. British Journal of Cancer 70(4): 690-693, 1994

Is the prognosis of young patients with hepatocellular carcinoma poorer than the prognosis of older patients? A comparative analysis of clinical characteristics, prognostic features, and survival outcome. Journal of Gastroenterology 43(11): 881-888, 2008

Clinical characteristics and survival outcomes of super-elderly hepatocellular carcinoma patients not indicated for surgical resection. Hepatology Research 46(3): E5, 2016

Clinical features and treatment of hepatocellular carcinoma in eight patients older than eighty years of age. Hepato-Gastroenterology 48(42): 1692-1696, 2002

Long-term outcome of elderly patients (75 years or older) with hepatocellular carcinoma. Hepatology Research 44(9): 975-982, 2014

Comparison of clinical characteristics and survival after surgery in patients with non-B and non-C hepatocellular carcinoma and hepatitis virus-related hepatocellular carcinoma. Journal of Cancer 4(6): 502-513, 2013

A multicenter retrospective study on clinical characteristics, treatment patterns, and outcome in elderly patients with hepatocellular carcinoma. Oncologist 16(3): 310-318, 2011

Efficacy and safety of sorafenib in very elderly patients aged 80 years and older with advanced hepatocellular carcinoma. Hepatology Research 44(13): 1329-1338, 2014

Surgical outcomes and prognostic factors in elderly patients (75 years or older) with hepatocellular carcinoma who underwent hepatectomy. Journal of Nippon Medical School 80(6): 426-432, 2013

Hepatic resection for hepatocellular carcinoma in super-elderly patients aged 80 years and older in the first decade of the 21st century. Surgery Today 45(7): 851-857, 2015

Clinical impact of postprogression survival for overall survival in elderly patients (aged 75 years or older) with advanced nonsmall cell lung cancer. Journal of Cancer Research and Therapeutics 11(3): 606-611, 2016

Clinical characteristics of hepatocellular carcinoma in elderly patients. Oncology Letters 2(5): 851-854, 2011